| Platelets, immune cells and the coagulation cascade; friend or foe of the circulating tumour cell? MP Ward, L E Kane, L A Norris, BM Mohamed, T Kelly, M Bates, A Clarke, ... Molecular cancer 20, 1-17, 2021 | 83 | 2021 |
| Protein phosphatase 2A regulation of markers of extracellular matrix remodelling in hepatocellular carcinoma cells: functional consequences for tumour invasion MP Ward, JP Spiers British journal of pharmacology 174 (10), 1116-1130, 2017 | 26 | 2017 |
| Increased extracellular vesicles mediate inflammatory signalling in cystic fibrosis Z Useckaite, MP Ward, A Trappe, R Reilly, J Lennon, H Davage, ... Thorax 75 (6), 449-458, 2020 | 20 | 2020 |
| BAG3 promotes tumour cell proliferation by regulating EGFR signal transduction pathways in triple negative breast cancer S Shields, E Conroy, T O’Grady, A McGoldrick, K Connor, MP Ward, ... Oncotarget 9 (21), 15673, 2018 | 20 | 2018 |
| HE4 and CA125 as preoperative risk stratifiers for lymph node metastasis in endometrioid carcinoma of the endometrium: a retrospective study in a cohort with histological proof … SA O'Toole, Y Huang, L Norris, MP Foley, R Shireen, S McDonald, ... Gynecologic Oncology 160 (2), 514-519, 2021 | 16 | 2021 |
| A risk score for prediction of venous thromboembolism in gynecologic cancer: The Thrombogyn score LA Norris, MP Ward, SA O'Toole, Z Marchocki, N Ibrahim, AS Khashan, ... Research and Practice in Thrombosis and Haemostasis, 2020 | 16 | 2020 |
| Circulating tumour cell enumeration does not correlate with Miller–Payne grade in a cohort of breast cancer patients undergoing neoadjuvant chemotherapy SA O’Toole, C Spillane, Y Huang, MC Fitzgerald, B Ffrench, B Mohamed, ... Breast Cancer Research and Treatment 181, 571-580, 2020 | 15 | 2020 |
| Aberrant protein expression of Appl1, Sortilin and Syndecan-1 during the biological progression of prostate cancer C Martini, JM Logan, A Sorvina, C Gordon, AR Beck, BSY Ung, ... Pathology 55 (1), 40-51, 2023 | 13 | 2023 |
| Could MicroRNAs be useful tools to improve the diagnosis and treatment of rare gynecological cancers? A brief overview R Di Fiore, S Suleiman, F Pentimalli, SA O’toole, JJ O’leary, MP Ward, ... International journal of molecular sciences 22 (8), 3822, 2021 | 13 | 2021 |
| LncRNA MORT (ZNF667-AS1) in Cancer—Is There a Possible Role in Gynecological Malignancies? R Di Fiore, S Suleiman, R Drago-Ferrante, A Felix, SA O’Toole, ... International journal of molecular sciences 22 (15), 7829, 2021 | 10 | 2021 |
| An overview of the role of long non-coding RNAs in human choriocarcinoma R Di Fiore, S Suleiman, A Felix, SA O’Toole, JJ O’Leary, MP Ward, ... International journal of molecular sciences 22 (12), 6506, 2021 | 10 | 2021 |
| Prediction of prostate cancer biochemical and clinical recurrence is improved by IHC-assisted grading using Appl1, Sortilin and Syndecan-1 JM Logan, AM Hopkins, C Martini, A Sorvina, P Tewari, S Prabhakaran, ... Cancers 15 (12), 3215, 2023 | 7 | 2023 |
| Circulating tumour cells: The Good, the Bad and the Ugly M Bates, BM Mohamed, MP Ward, TE Kelly, R O’Connor, V Malone, ... Biochimica et Biophysica Acta (BBA)-Reviews on Cancer 1878 (2), 188863, 2023 | 7 | 2023 |
| The induction of a mesenchymal phenotype by platelet cloaking of cancer cells is a universal phenomenon CD Spillane, NM Cooke, MP Ward, D Kenny, G Blackshields, T Kelly, ... Translational Oncology 14 (12), 101229, 2021 | 7 | 2021 |
| Ex vivo expansion of circulating tumour cells (CTCs) BM Mohamed, MP Ward, M Bates, CD Spillane, T Kelly, C Martin, ... Scientific Reports 13 (1), 3704, 2023 | 6 | 2023 |
| (In) distinctive role of long non-coding RNAs in common and rare ovarian cancers M Sabol, J Calleja-Agius, R Di Fiore, S Suleiman, S Ozcan, MP Ward, ... Cancers 13 (20), 5040, 2021 | 6 | 2021 |
| Procoagulant activity in high grade serous ovarian cancer patients following neoadjuvant chemotherapy-the role of the activated protein C pathway MP Ward, FA Saadeh, SA O'Toole, JJ O'Leary, N Gleeson, LA Norris Thrombosis Research 200, 91-98, 2021 | 5 | 2021 |
| Dynamic interplay between sortilin and syndecan-1 contributes to prostate cancer progression J Lazniewska, KL Li, IRD Johnson, A Sorvina, JM Logan, C Martini, ... Scientific reports 13 (1), 13489, 2023 | 2 | 2023 |
| Development and validation of a risk model for prediction of venous thromboembolism in gynaecological cancer patients LA Norris, FA Saadeh, M Ward, SA O'Toole, Z Machocki, N Ibrahim, ... Thrombosis Research 164, S183-S184, 2018 | 2 | 2018 |
| Plasminogen activator inhibitor 1 is associated with high-grade serous ovarian cancer metastasis and is reduced in patients who have received neoadjuvant chemotherapy TE Kelly, CL Spillane, MP Ward, K Hokamp, Y Huang, P Tewari, ... Frontiers in Cell and Developmental Biology 11, 2023 | 1 | 2023 |
Paul SpiersTrinity College DublinVerified email at tcd.ie
Paul SpiersTrinity College DublinVerified email at tcd.ie